Journal Impact Factor 1.0* ; 1.93* (5 Year Impact Factor)
International Journal of Clinical Rheumatology is at the cutting edge of the most recent clinical, translational and lab based exploration to propel the treatment for a wide range of rheumatic diseases and disorders which includes themes, for example, treatment, surgery, imaging and clinical education.
The journal is committed to distribute most elevated quality studies identified with clinical determination and administration of rheumatic ailments through facilitated parts of clinical consideration and clinical examination concentrated on propelling treatment and personal satisfaction for individuals with joint pain, immune system infections, bone issue and related conditions. This journal offers an open access platform to Rheumatology community where, the authors can publish all the reliable sources of information on research findings and current developments as original articles, reviews, case studies, clinical images, short communications, commentaries, etc. and all the published materials will be accessed online all over the world without any subscription fee. The journal gives fundamental perusing to rheumatologists and additionally orthopedic specialists, pharmacologists, pathologists, radiologists, general experts and other wellbeing experts with an enthusiasm for patients with rheumatic maladies.
The journal also incorporates original papers inside the assorted fields of rheumatology, clinical experimentation as well as medicine, pathologic process, immunology, immunopathology, microbiology and different types of radiological studies.
Indexing: Scopus, Excerpta Medica (EMBASE), CAS (Chemical Abstracts)
Submit your manuscripts through Editorial Manager: http://www.editorialmanager.com/openaccessjournals
Case Report p. 2
Author(s): Stephen Boyle, Veena Dhillon, Angus Broom & John R Goodlad
Subcutaneous panniculitis-like T-cell Lymphoma (SPTL) is a rare extranodal lymphoma that accounts for less than 1% of all Non-Hodgkin Lymphomas. We describe SPTL in a patient with Juvenile I..
Case Report p. 5
Author(s): Mohammed Omair, Rashid AlBallaa, Eman Alqurtas & Waleed Al-Habeeb
There is growing evidence on the potential benefits of tocilizumab on the cardiovascular system in Rheumatoid Arthritis (RA) patients. We discuss a case of active RA and refractory Heart Fai..